Vivendy Therapeutics Company

Vivendy Therapeutics Ltd. engages in the development of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency.

The company was founded in 2006 and is based in Basel, Switzerland.


Technology: Prevention
Industry: Regenerative medicine
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 2006
Employees Number: 1-10
Funding Status: Early Stage Venture
Register and Claim Ownership